Superior HbA1c control with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with a maximum dose of 50 units of insulin degludec in Japanese individuals with type 2 diabetes in a phase 3, double‐blind, randomized trial

AIMS: To investigate the efficacy and safety of insulin degludec/liraglutide (IDegLira) compared with 50 U insulin degludec (degludec) or less in Japanese individuals with type 2 diabetes (T2D). MATERIALS AND METHODS: In this 26‐week, double‐blind, multicentre, treat‐to‐target trial, Japanese indivi...

Descripción completa

Detalles Bibliográficos
Autores principales: Watada, Hirotaka, Kaneko, Shizuka, Komatsu, Mitsuhisa, Agner, Bue Ross, Nishida, Tomoyuki, Ranthe, Mattis, Nakamura, Jiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900157/
https://www.ncbi.nlm.nih.gov/pubmed/31423685
http://dx.doi.org/10.1111/dom.13859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900157/
https://www.ncbi.nlm.nih.gov/pubmed/31423685
http://dx.doi.org/10.1111/dom.13859

Ejemplares similares